J. Michael Pearson Insider Trading $ICN VALEANT PHARMACEUTICALS INTERNATIONAL
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for J. Michael Pearson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J. Michael Pearson. J. Michael Pearson is CEO and Chairman in VALEANT PHARMACEUTICALS INTERNATIONAL ($ICN) and CEO and Chairman of the Board in VALEANT PHARMACEUTICALS INTERNATIONAL ($ICN) and Chief Executive Officer in Valeant Pharmaceuticals International, Inc. ($BVF).
J. Michael Pearson in VALEANT PHARMACEUTICALS INTERNATIONAL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Michael Pearson: CEO and Chairman of the Board
Holdings: 0 shares
Latest Transaction: Oct 20 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J. Michael Pearson in VALEANT PHARMACEUTICALS INTERNATIONAL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Option Exercise | D | 37.41 | 500,000 | 18,705,000 | 0 | |
| Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Option Exercise | D | 12.19 | 1,024,591 | 12,489,764 | 0 | |
| Oct 20 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman | Sell | D | 0.00 | 1,931,505 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
| Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 21,252 | 716,617 | 1,004,198 | 1 M to 1 M (-2.07 %) |
| Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 4,627 | 156,022 | 1,025,450 | 1 M to 1 M (-0.45 %) |
| Feb 03 2010 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 33.72 | 5,961 | 201,005 | 1,030,077 | 1 M to 1 M (-0.58 %) |
| Dec 08 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 31.93 | 188,875 | 6,030,779 | 1,036,038 | 1.2 M to 1 M (-15.42 %) |
| Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 37.41 | 500,000 | 18,705,000 | 500,000 | |
| Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 0.00 | 173,750 | 0 | 173,750 | |
| Dec 03 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 0.00 | 200,481 | 0 | 200,481 | |
| Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 5,960 | 147,391 | 1,224,913 | 1.2 M to 1.2 M (-0.48 %) |
| Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 22,945 | 567,430 | 1,230,873 | 1.3 M to 1.2 M (-1.83 %) |
| Jul 27 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Payment of Exercise | F | 24.73 | 5,898 | 145,858 | 1,253,818 | 1.3 M to 1.3 M (-0.47 %) |
| May 08 2009 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 18.51 | 7,000 | 129,570 | 1,259,716 | 1.3 M to 1.3 M (+0.56 %) |
| Aug 19 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 51,440 | 0 | 845,218 | 793.8 K to 845.2 K (+6.48 %) |
| Jul 11 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 198,013 | 0 | 793,778 | 595.8 K to 793.8 K (+33.24 %) |
| Jul 10 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 50,906 | 0 | 396,817 | 345.9 K to 396.8 K (+14.72 %) |
| Jul 07 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.20 | 51,440 | 833,328 | 544,859 | 493.4 K to 544.9 K (+10.43 %) |
| Jun 27 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 17.09 | 48,761 | 833,325 | 493,419 | 444.7 K to 493.4 K (+10.97 %) |
| Jun 20 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 17.06 | 48,847 | 833,330 | 444,658 | 395.8 K to 444.7 K (+12.34 %) |
| Jun 16 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.70 | 49,900 | 833,330 | 395,811 | 345.9 K to 395.8 K (+14.43 %) |
| Jun 09 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.50 | 50,505 | 833,333 | 345,911 | 295.4 K to 345.9 K (+17.10 %) |
| Jun 03 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Buy | P | 16.37 | 50,906 | 833,331 | 295,406 | 244.5 K to 295.4 K (+20.82 %) |
| Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 12.19 | 991,779 | 12,089,786 | 991,779 | |
| Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Option Exercise | A | 12.19 | 32,812 | 399,978 | 32,812 | |
| Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 81,500 | 0 | 244,500 | 163 K to 244.5 K (+50.00 %) |
| Feb 05 2008 | ICN | VALEANT PHARMACEUT ... | Pearson J. Michael | CEO and Chairman of ... | Grant | A | 0.00 | 163,000 | 0 | 163,000 | 0 to 163 K |
Page: 1